Table 2. Baseline characteristics of all the participating HIV/HBV co-infected individuals belonging to different HBV genotypes.
| Variable | Total HIV/HBV patients | Genotype | ||
| HBV/A | HBV/C | HBV/D | ||
| Patients, n (%) | 59 | 19 (32.2) | 6 (10.2) | 34 (57.6) |
| Age, years, median (IQR) | 35 (21–60) | 35 (21–60) | 33.5 (26–50) | 34.5 (32–54) |
| Male sex, n (%) | 53 (89.8) | 17 (89.5) | 6 (100) | 30 (88.2) |
| CD4+ T-cell count, cells/mm3, median (IQR) | 198 (26–838) | 144 (61–838) | 319.5 (186–629) | 194 (26–414) |
| ALT, U/L, median (IQR) | 50 (15–406) | 54 (15–186) | 52 (17–406) | 45 (22–182) |
| HBeAg positive, n (%) | 46 (78) | 15 (79) | 4 (66.7) | 27 (79.4) |
| HBV DNA, log10IU/ml, median (IQR) | 5.7 (2–7.65) | 5.7 (2–7.64) | 4.9 (4.62–5.96) | 5.8 (4.37–7.65) |